Similar articles

• Factors influencing thromboembolic complications in Omniscience cardiac valve patients.

  Dewall R, Pelletier LC, Panebianco A, Hicks G, Schuster B, Bonan R, Martineau JP, Yip L. Dewall R, et al. Eur Heart J. 1984 Oct;5 Suppl D:53-7. doi: 10.1093/eurheartj/5.suppl_d.53. Eur Heart J. 1984. PMID: 6519103
• [Replacement of the mitral and aortic valves with bioprostheses. Long-term results].

  Colombo T, Cicardi C, Peronace B, Pozzi M, Gordini V, Pellegrini A. Colombo T, et al. G Ital Cardiol. 1985 Oct;15(10):974-82. G Ital Cardiol. 1985. PMID: 4092917 Italian.
• [Complications in patients with artificial heart valves].

  Lang KF, Moelle P, Just H, Limbourg P, Satter P, vd Emde J. Lang KF, et al. Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:349-51. Verh Dtsch Ges Inn Med. 1977. PMID: 611979 German. No abstract available.
• Thromboembolic complications of current cardiac valvular prostheses.

  Edmunds LH Jr. Edmunds LH Jr. Ann Thorac Surg. 1982 Jul;34(1):96-106. doi: 10.1016/s0003-4975(10)60862-4. Ann Thorac Surg. 1982. PMID: 7046665 Review.
• [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].

  Trzeciak P, Poloński L, Zembala M. Trzeciak P, et al. Kardiol Pol. 2006 Sep;64(9):1038-42. Kardiol Pol. 2006. PMID: 17054041 Review. Polish. No abstract available.